Status:
COMPLETED
Use of High Sensitivity Cardiac Troponin in Ruling Out Emergency Patients with Acute Myocardial Injury and Infarction
Lead Sponsor:
Hennepin Healthcare Research Institute
Collaborating Sponsors:
Siemens Healthineers
Conditions:
Acute Myocardial Infarction
Acute Coronary Syndrome
Eligibility:
All Genders
18+ years
Brief Summary
Examine the analytical and clinical performance of Atellica IM TnIH assay for the diagnosis and rule out of acute myocardial injury and myocardial infarction in patients presenting to the emergency de...
Detailed Description
Background: Studies addressing the clinical performance of the Siemens Healthineers High-Sensitivity Troponin I assay (TnIH) on the Atellica IM analyzer for the diagnosis and rule out of acute myocard...
Eligibility Criteria
Inclusion
- Baseline cTn measurement and at least one additional cTn measurement within 6 hours after initial measurement.
- At least one 12-lead electrocardiogram
Exclusion
- Less than 18 years old
- Pregnancy
- Trauma
- Decline to participate
- Did not present through the ED
- Transferred from an outside hospital or clinic.
Key Trial Info
Start Date :
October 13 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 13 2024
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT04280926
Start Date
October 13 2020
End Date
October 13 2024
Last Update
December 17 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hennepin Healthcare Research Institute / Hennepin County Medical Center
Minneapolis, Minnesota, United States, 55404